作者:
Gavrielov-Yusim, Natalie [1]
;
Kurzinger, Marie-Laure [2]
;
Nishikawa, Chihiro [3]
;
Pan, Chunshen [4]
;
Pouget, Julie [5]
;
Epstein, Limor B. H. [6]
;
Golant, Yan ;
Tcherny-Lessenot, Stephanie ;
Lin, Stephen ;
Hamelin, Bernard ;
Juhaeri, Juhaeri
作者单位:
Sanofi, Epidemiol & Benefit Risk Evaluat, Chilly Mazarin, France
[1]
Sanofi, Global Pharmacovigilance, Bridgewater, NJ USA
[2]
Sanofi, Epidemiol & Benefit Risk Evaluat, Bridgewater, NJ USA
[3]
Data2Life, R&D, 14 Beit Hillel St, Tel Aviv, Israel
[4]
Sanofi, Med Evidence Generat, Paris, France
[5]
Sanofi, R&D CMO SC Real World Evidence, Informat Technol & Solut, Lyon, France
[6]
发布时间
2020-09-03